| Announce Date | 12/18/2025 |
| EPS Normalized Actual | $1.21 (Beat by $0.01) |
| EPS GAAP Actual | $1.21 (Beat by $0.01) |
| Revenue Actual | $2.79999B |
| Revenue Surprise | Beat by $2799.99M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| May 2030 | 0 | INF | 0 | 0 | 5 |
| May 2029 | 6.47 | 30.27 | 6.41013 | 6.53417 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 1.22 | 1.22 | 2.79999B | 8.51% | 2799.99M |
| FQ3 2025 (Aug 2025) | 1.21 | 1.21 | 2.71812B | 7.97% | 2718.12M |
| FQ2 2025 (May 2025) | 1.11 | 1.11 | 2.66765B | 7.37% | 2667.65M |
| FQ1 2025 (Feb 2025) | 1.14 | 1.14 | 2.60916B | 7.78% | 2609.16M |
| FQ4 2024 (Nov 2024) | -1.12 | -1.12 | 2.56178B | 7.21% | 2561.78M |
| FQ3 2024 (Aug 2024) | 1.12 | 1.12 | 2.50159B | 6.37% | 2501.59M |
| FQ2 2024 (May 2024) | 4.08 | 4.08 | 2.47094B | 7.55% | 2470.94M |
| FQ1 2024 (Feb 2024) | 3.92 | 3.92 | 2.40617B | 8.98% | 2406.17M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (May 2028) | 1.43664 | -- | 1.42761 | 1.44608 | 4 |
| FQ1 2028 (Feb 2028) | 1.36634 | -- | 1.36634 | 1.36634 | 5 |
| FQ4 2027 (Nov 2027) | 1.41326 | -- | 1.41326 | 1.41326 | 4 |
| FQ3 2027 (Aug 2027) | 1.4206 | -- | 1.41168 | 1.42994 | 3 |
| FQ2 2027 (May 2027) | 4.89251 | -- | 4.89251 | 4.89251 | 5 |
| FQ1 2027 (Feb 2027) | 1.21615 | -- | 1.20513 | 1.23168 | 7 |
| FQ4 2026 (Nov 2026) | 1.29225 | 5.59 | 1.28562 | 1.3027 | 7 |
| FQ3 2026 (Aug 2026) | 4.87662 | 75.19 | 4.87662 | 4.87662 | 5 |
| FQ2 2026 (May 2026) | 1.20191 | 7.65 | 1.19442 | 1.20841 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (May 2028) | 3.23B | -- | 3.21B | 3.24B | 5 |
| FQ1 2028 (Feb 2028) | 3.15B | -- | 3.15B | 3.15B | 4 |
| FQ4 2027 (Nov 2027) | 3.11B | -- | 3.11B | 3.11B | 5 |
| FQ3 2027 (Aug 2027) | 3.07B | -- | 3.05B | 3.08B | 8 |
| FQ2 2027 (May 2027) | 2.93B | -- | 2.93B | 2.93B | 5 |
| FQ1 2027 (Feb 2027) | 2.91B | -- | 2.89B | 2.94B | 8 |
| FQ4 2026 (Nov 2026) | 2.92B | 4.04 | 2.91B | 2.94B | 6 |
| FQ3 2026 (Aug 2026) | 2.79B | 2.72 | 2.79B | 2.79B | 5 |
| FQ2 2026 (May 2026) | 2.81B | 4.9 | 2.79B | 2.82B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 1.22 | 1.22 | 100% | |
| FQ3 2025 (Aug 2025) | 1.21 | 1.21 | 100% | |
| FQ2 2025 (May 2025) | 1.11 | 1.11 | 100% | |
| FQ1 2025 (Feb 2025) | 1.14 | 1.14 | 100% | |
| FQ4 2024 (Nov 2024) | -1.12 | -1.12 | 100% | |
| FQ3 2024 (Aug 2024) | 1.12 | 1.12 | 100% | |
| FQ2 2024 (May 2024) | 4.08 | 4.08 | 100% | |
| FQ1 2024 (Feb 2024) | 3.92 | 3.92 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $2.8B | $2799.99M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $2.72B | $2718.12M | 100% |
| FQ2 2025 (May 2025) | $0B | $2.67B | $2667.65M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $2.61B | $2609.16M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $2.56B | $2561.78M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $2.5B | $2501.59M | 100% |
| FQ2 2024 (May 2024) | $0B | $2.47B | $2470.94M | 100% |
| FQ1 2024 (Feb 2024) | $0B | $2.41B | $2406.17M | 100% |